Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Antibacterial activity and mechanism of berberine against Streptococcus agalactiae. β
International journal of clinical and experimental pathology (Int J Clin Exp Pathol ) Vol: 8 Issue 5 Pages: 5217-23 Pub: 2015 Epub: 2015 May 1 Authors Peng L , Kang S , Yin Z , Jia R , Song X , Li L , Li Z , Zou Y , Liang X , Li L , He C , Ye G , Yin L , Shi F , Lv C , Jing B , |
|
|
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. β
Go to Publication β
Scientific reports (Sci Rep ) Vol: 5 Issue Pages: 14405 Pub: 2015 Sep 23 Epub: 2015 Sep 23 Authors Zhang X , Zhao Y , Xu J , Xue Z , Zhang M , Pang X , Zhang X , Zhao L , |
|
|
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. β
Go to Publication β
Scientific reports (Sci Rep ) Vol: 5 Issue Pages: 14405 Pub: 2015 Sep 23 Epub: 2015 Sep 23 Authors Zhang X , Zhao Y , Xu J , Xue Z , Zhang M , Pang X , Zhang X , Zhao L , |
|
|
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. β
Go to Publication β
Scientific reports (Sci Rep ) Vol: 5 Issue Pages: 14405 Pub: 2015 Sep 23 Epub: 2015 Sep 23 Authors Zhang X , Zhao Y , Xu J , Xue Z , Zhang M , Pang X , Zhang X , Zhao L , |
|
|
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. β
Go to Publication β
Scientific reports (Sci Rep ) Vol: 5 Issue Pages: 14405 Pub: 2015 Sep 23 Epub: 2015 Sep 23 Authors Zhang X , Zhao Y , Xu J , Xue Z , Zhang M , Pang X , Zhang X , Zhao L , |
|
|
Modulation of Gut Microbiota by Berberine Improves Steatohepatitis in High-Fat Diet-Fed BALB/C Mice. β
Go to Publication β
Archives of Iranian medicine (Arch Iran Med ) Vol: 19 Issue 3 Pages: 197-203 Pub: 2016 Mar Epub: Authors Cao Y , Pan Q , Cai W , Shen F , Chen GY , Xu LM , Fan JG , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. β
Go to Publication β
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. β
Go to Publication β
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. β
Go to Publication β
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. β
Go to Publication β
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
|
Significant pharmacokinetic differences of berberine are attributable to variations in gut microbiota between Africans and Chinese. β
Go to Publication β
Scientific reports (Sci Rep ) Vol: 6 Issue Pages: 27671 Pub: 2016 Jun 10 Epub: 2016 Jun 10 Authors Alolga RN , Fan Y , Chen Z , Liu LW , Zhao YJ , Li J , Chen Y , Lai MD , Li P , Qi LW , |
|
|
Dietary prophage inducers and antimicrobials: toward landscaping the human gut microbiome. β
Go to Publication β
Gut microbes (Gut Microbes ) Vol: Issue Pages: 1-14 Pub: 2020 Jan 13 Epub: 2020 Jan 13 Authors Boling L , Cuevas DA , Grasis JA , Kang HS , Knowles B , Levi K , Maughan H , McNair K , Rojas MI , Sanchez SE , Smurthwaite C , Rohwer F , |
|
|
Berberine alters gut microbial function through modulation of bile acids. β
Go to Publication β
BMC microbiology (BMC Microbiol ) Vol: 21 Issue 1 Pages: 24 Pub: 2021 Jan 11 Epub: 2021 Jan 11 Authors Wolf PG , Devendran S , Doden HL , Ly LK , Moore T , Takei H , Nittono H , Murai T , Kurosawa T , Chlipala GE , Green SJ , Kakiyama G , Kashyap P , McCracken VJ , Gaskins HR , Gillevet PM , Ridlon JM , |
|
|
Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice. β
Go to Publication β
Frontiers in pharmacology (Front Pharmacol ) Vol: 11 Issue Pages: 223 Pub: 2020 Epub: 2020 Mar 13 Authors Wu M , Yang S , Wang S , Cao Y , Zhao R , Li X , Xing Y , Liu L , |
|
|
Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice. β
Go to Publication β
Frontiers in pharmacology (Front Pharmacol ) Vol: 11 Issue Pages: 223 Pub: 2020 Epub: 2020 Mar 13 Authors Wu M , Yang S , Wang S , Cao Y , Zhao R , Li X , Xing Y , Liu L , |
|
|
Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice. β
Go to Publication β
Frontiers in pharmacology (Front Pharmacol ) Vol: 11 Issue Pages: 223 Pub: 2020 Epub: 2020 Mar 13 Authors Wu M , Yang S , Wang S , Cao Y , Zhao R , Li X , Xing Y , Liu L , |
|
|
Berberine hydrochloride alleviates chronic prostatitis/chronic pelvic pain syndrome by modifying gut microbiome signaling. β
Go to Publication β
Asian journal of andrology (Asian J Androl ) Vol: Issue Pages: Pub: 2024 Jul 16 Epub: 2024 Jul 16 Authors Tian YQ , Ren X , Wang J , Li X , Yin YS , Guo ZH , Qin ZL , Zeng XY , |
|
|
Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids. β
Go to Publication β
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 131 Issue Pages: 110669 Pub: 2020 Nov Epub: 2020 Sep 13 Authors Yao Y , Chen H , Yan L , Wang W , Wang D , |
|
|
Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats. β
Go to Publication β
Pharmacognosy magazine (Pharmacogn Mag ) Vol: 13 Issue 52 Pages: 677-682 Pub: 2017 Oct-Dec Epub: 2017 Nov 13 Authors Li D , Zheng J , Hu Y , Hou H , Hao S , Liu N , Wang Y , |
|
|
Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats. β
Go to Publication β
Pharmacognosy magazine (Pharmacogn Mag ) Vol: 13 Issue 52 Pages: 677-682 Pub: 2017 Oct-Dec Epub: 2017 Nov 13 Authors Li D , Zheng J , Hu Y , Hou H , Hao S , Liu N , Wang Y , |
|
|
Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats. β
Go to Publication β
Pharmacognosy magazine (Pharmacogn Mag ) Vol: 13 Issue 52 Pages: 677-682 Pub: 2017 Oct-Dec Epub: 2017 Nov 13 Authors Li D , Zheng J , Hu Y , Hou H , Hao S , Liu N , Wang Y , |
|
|
Modulation of gut microbiota mediates berberine-induced expansion of immuno-suppressive cells to against alcoholic liver disease. β
Go to Publication β
Clinical and translational medicine (Clin Transl Med ) Vol: 10 Issue 4 Pages: e112 Pub: 2020 Aug Epub: 2020 Aug 13 Authors Li S , Wang N , Tan HY , Chueng F , Zhang ZJ , Yuen MF , Feng Y , |
|
|
Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites. β
Go to Publication β
Pharmacological research (Pharmacol Res ) Vol: 164 Issue Pages: 105358 Pub: 2021 Feb Epub: 2020 Dec 4 Authors Jing W , Dong S , Luo X , Liu J , Wei B , Du W , Yang L , Luo H , Wang Y , Wang S , Lu H , |
|
|
Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/Γ-catenin pathway. β
Go to Publication β
International journal of biological sciences (Int J Biol Sci ) Vol: 18 Issue 4 Pages: 1381-1397 Pub: 2022 Epub: 2022 Jan 16 Authors Dong Y , Fan H , Zhang Z , Jiang F , Li M , Zhou H , Guo W , Zhang Z , Kang Z , Gui Y , Shou Z , Li J , Zhu R , Fu Y , Sarapultsev A , Wang H , Luo S , Zhang G , Hu D , |
|
|
Berberine inhibits dendritic cells differentiation in DSS-induced colitis by promoting Bacteroides fragilis. β
Go to Publication β
International immunopharmacology (Int Immunopharmacol ) Vol: 101 Issue Pt A Pages: 108329 Pub: 2021 Dec Epub: 2021 Nov 5 Authors Zheng C , Wang Y , Xu Y , Zhou L , Hassan S , Xu G , Zou X , Zhang M , |
|
|
A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis. β
Go to Publication β
Frontiers in immunology (Front Immunol ) Vol: 11 Issue Pages: 588079 Pub: 2020 Epub: 2020 Sep 24 Authors Chen H , Zhang F , Zhang J , Zhang X , Guo Y , Yao Q , |
|
|
Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota. β
Go to Publication β
Nutrients (Nutrients ) Vol: 14 Issue 4 Pages: Pub: 2022 Feb 9 Epub: 2022 Feb 9 Authors Deng J , Zhao L , Yuan X , Li Y , Shi J , Zhang H , Zhao Y , Han L , Wang H , Yan Y , Zhao H , Wang H , Zou F , |
|
|
Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota. β
Go to Publication β
Pharmacological research (Pharmacol Res ) Vol: 165 Issue Pages: 105439 Pub: 2021 Mar Epub: 2021 Jan 22 Authors Fang Y , Zhang J , Zhu S , He M , Ma S , Jia Q , Sun Q , Song L , Wang Y , Duan L , |
|
|
Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota. β
Go to Publication β
Pharmacological research (Pharmacol Res ) Vol: 165 Issue Pages: 105439 Pub: 2021 Mar Epub: 2021 Jan 22 Authors Fang Y , Zhang J , Zhu S , He M , Ma S , Jia Q , Sun Q , Song L , Wang Y , Duan L , |
|
|
Effects of Berberine on Gut Microbiota in Patients with Mild Metabolic Disorders Induced by Olanzapine. β
Go to Publication β
The American journal of Chinese medicine (Am J Chin Med ) Vol: 49 Issue 8 Pages: 1949-1963 Pub: 2021 Epub: Authors Pu Z , Sun Y , Jiang H , Hou Q , Yan H , Wen H , Li G , |
|
|
Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids. β
Planta medica (Planta Med ) Vol: 67 Issue 6 Pages: 561-4 Pub: 2001 Aug Epub: Authors Scazzocchio F , Cometa MF , Tomassini L , Palmery M , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
